mirvetuximab
immunogen
['mirasol', 'gyn', 'ovarian']
i shared tweets others wrote about the mirasol trial (mirvetixumab in folr1 positive platinum resistant #ovariancancer ) but... this slide says it all . #asco23 #gyncsm 
#ovca survivor; research advocate; author; co-moderator #gyncsm chat;  #ASCO22 Feature Voice  COI: https://t.co/AUF1EprNVt Opinions are my own.